Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ImmunoPrecise Antibodies ...

    NASDAQ: IPA · Real-Time Price · USD
    0.47
    0.01 (1.64%)
    At close: May 02, 2025, 12:28 PM
    1.64%
    Bid 0.46
    Market Cap 21.42M
    Revenue (ttm) 24M
    Net Income (ttm) -46.12M
    EPS (ttm) -1.21
    PE Ratio (ttm) -0.39
    Forward PE -2.2
    Analyst Buy
    Ask 0.47
    Volume 452,938
    Avg. Volume (20D) 1,896,817
    Open 0.47
    Previous Close 0.46
    Day's Range 0.45 - 0.48
    52-Week Range 0.27 - 1.36
    Beta 0.38

    About IPA

    ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services incl...

    [Read more]
    Industry Biotechnology
    Sector Healthcare
    IPO Date Jan 7, 2002
    Employees 72
    Stock Exchange NASDAQ
    Ticker Symbol IPA
    Website https://www.ipatherapeutics.com
    Full Company Profile

    Analyst Forecast

    According to 2 analyst ratings, the average rating for IPA stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 754.70% from the latest price.

    Stock Forecasts

    Next Earnings Release

    ImmunoPrecise Antibodies Ltd. is scheduled to release its earnings on Jul 28, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +11.48%
    ImmunoPrecise Antibodies shares are trading higher... Unlock content with Pro Subscription
    2 months ago
    -3.95%
    ImmunoPrecise Antibodies shares are trading higher after the company announced a collaboration with RIBOPRO.
    news image

    2 weeks ago · businesswire.com

    ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced its strong support for the U.S. Food and Drug Admi...

    news image

    4 weeks ago · zacks.com

    ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock?

    ImmunoPrecise Antibodies (IPA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    news image

    1 month ago · seekingalpha.com

    ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript

    ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - In...

    news image

    1 month ago · zacks.com

    ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates

    ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate.

    news image

    1 month ago · businesswire.com

    ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today reported financial...

    news image

    1 month ago · businesswire.com

    ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is pleased to announce a strategic partnership with a leading biotechnology company with a multi-billion-...

    news image

    1 month ago · businesswire.com

    IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and development, today announces the...

    news image

    1 month ago · businesswire.com

    IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and development, today announced tha...

    news image

    2 months ago · businesswire.com

    ImmunoPrecise Antibodies Announces Key Leadership Changes

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, is pleased to announce key le...

    news image

    2 months ago · businesswire.com

    ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and development, today announced tha...

    Create Price Alert on IPA

    Your price alert will notify you when the stock price is above 0.47.

    Add to Watchlist